日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Characterization of human induced pluripotent stems cells: Current approaches, challenges, and future solutions

人类诱导性多能干细胞的表征：当前方法、挑战和未来解决方案

期刊:Biotechnology Reports
影响因子:
doi:10.1016/j.btre.2023.e00784
Sahana Suresh Babu, Haritha Duvvuru, Jillian Baker, Stephanie Switalski, Mehdi Shafa, Krishna Morgan Panchalingam, Saedeh Dadgar, Justin Beller, Behnam Ahmadian Baghbaderani
发育与干细胞
干细胞
发表日期：2023
文献求助 收藏

Computational fluid dynamics modeling, a novel, and effective approach for developing scalable cell therapy manufacturing processes

计算流体动力学建模是开发可扩展细胞治疗制造工艺的一种新颖、有效的方法

期刊:Biotechnology and Bioengineering
影响因子:3.5
doi:10.1002/bit.27159
Mehdi Shafa, Krishna M Panchalingam, Tylor Walsh, Thomas Richardson, Behnam Ahmadian Baghbaderani
细胞生物学
其它细胞
FCM
IF
IHC-P
WB
NKX25
发表日期：2019
文献求助 收藏

Long-Term Stability and Differentiation Potential of Cryopreserved cGMP-Compliant Human Induced Pluripotent Stem Cells

冷冻保存的符合cGMP标准的人类诱导多能干细胞的长期稳定性和分化潜能

期刊:International Journal of Molecular Sciences
影响因子:0.7
doi:10.3390/ijms21010108
Mehdi Shafa ，Tylor Walsh ，Krishna Morgan Panchalingam ，Thomas Richardson ，Laura Menendez ，Xinghui Tian ，Sahana Suresh Babu ，Saedeh Dadgar ，Justin Beller ，Fan Yang ，Behnam Ahmadian Baghbaderani
细胞生物学
干细胞
发育与干细胞
Human
发表日期：2019
文献求助 收藏

Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers

采用符合现行良好生产规范的工艺制造的人类诱导性多能干细胞可从三个胚层分化为临床相关细胞

期刊:Frontiers in Medicine
影响因子:
doi:10.3389/fmed.2018.00069
Mehdi Shafa, Fan Yang, Thomas Fellner, Mahendra S Rao, Behnam Ahmadian Baghbaderani
发育与干细胞
干细胞
Cell sorting
FCM
Human
发表日期：2018
文献求助 收藏

Investigation of tRNA(Leu/Lys) and ATPase 6 genes mutations in Huntington's disease

亨廷顿病中tRNA(Leu/Lys)和ATPase 6基因突变的研究

期刊:Cellular and Molecular Neurobiology
影响因子:4.8
doi:10.1007/s10571-008-9261-6
Kasraie, Sadaf; Houshmand, Massoud; Banoei, Mohammad Mehdi; Ahari, Solmaz Etemad; Panahi, Mehdi Shafa Shariat; Shariati, Parvin; Bahar, Mohammad; Moin, Mostafa
发表日期：2008
文献求助 收藏

Do haplogroups H and U act to increase the penetrance of Alzheimer's disease?

单倍群H和U是否会增加阿尔茨海默病的患病率？

期刊:Cellular and Molecular Neurobiology
影响因子:4.8
doi:10.1007/s10571-006-9126-9
Fesahat, Farzaneh; Houshmand, Massoud; Panahi, Mehdi Shafa Shariat; Gharagozli, Kurosh; Mirzajani, Farzaneh
阿尔茨海默症
发表日期：2007
文献求助 收藏

Investigation on mitochondrial tRNA(Leu/Lys), NDI and ATPase 6/8 in Iranian multiple sclerosis patients

对伊朗多发性硬化症患者线粒体tRNA(Leu/Lys)、NDI和ATPase 6/8的研究

期刊:Cellular and Molecular Neurobiology
影响因子:4.8
doi:10.1007/s10571-007-9160-2
Ahari, Solmaz Etemad; Houshmand, Massoud; Panahi, Mehdi Shafa Shariat; Kasraie, Sadaf; Moin, Mostafa; Bahar, Mohammad Ali
神经科学
线粒体
多发性硬化症
发表日期：2007
文献求助 收藏

Huntington's disease and mitochondrial DNA deletions: event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?!

亨廷顿病与线粒体DNA缺失：突变亨廷顿蛋白和CAG重复序列扩增的事件还是常规机制？！

期刊:Cellular and Molecular Neurobiology
影响因子:4.8
doi:10.1007/s10571-007-9206-5
Banoei, Mohammad Mehdi; Houshmand, Massoud; Panahi, Mehdi Shafa Shariat; Shariati, Parvin; Rostami, Maryam; Manshadi, Masoumeh Dehghan; Majidizadeh, Tayebeh
线粒体
发表日期：2007
文献求助 收藏

Mitochondrial D-loop variation in Persian multiple sclerosis patients: K and A haplogroups as a risk factor!!

波斯多发性硬化症患者线粒体D-loop区变异：K和A单倍群是风险因素！！

期刊:Cellular and Molecular Neurobiology
影响因子:4.8
doi:10.1007/s10571-006-9026-z
Hassani-Kumleh, Hassan; Houshmand, Massoud; Panahi, Mehdi Shafa Shariat; Riazi, Gholam Hossein; Sanati, Mohammad Hossein; Gharagozli, Kurosh; Ghabaee, Mojdeh
神经科学
线粒体
多发性硬化症
发表日期：2006
文献求助 收藏